Study of Temzolomide and Gleevec in Advanced Melanoma
Clinical trial NCT00667953 · TERMINATED
Trial details
- NCT number
- NCT00667953
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2011-03-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.